Abcam ? ab34712 ? Anti-Collagen II抗体

产品名称

Anti-Collagen II抗体
参阅全部 Collagen II 一抗

描述

兔多克隆抗体to Collagen II

宿主

Rabbit

特异性

This antibody reacts with Type II collagens and shows negligible (less than 1%) cross reactivity with Type I, III, IV, V or VI collagens. Nonspecific cross reaction with other human serum proteins or non collagen extracellular matrix proteins is negligible.

经测试应用

适用于:?ELISA,?IP,?ICC/IF,?IHC-P,?WBmore details

种属反应性

与反应:?Mouse, Rat, Sheep, Chicken, Cow, Dog, Human, Pig
预测可用于:?Mammals

免疫原

Full length protein corresponding to Human Collagen II. Collagen Type II from human knee cartilage and bovine nasal cartilage.

阳性对照

IHC-P: Human bronchiolar cartilage; Human Mesenchymal stem cells; Human HEMC-SS spheroids.

Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I


描述

搜索关键词:

Extracellular Matrix (ECM) 细胞外基质;Gelatin 明胶;Collagen Type I 胶原蛋白I型;Poly-L-lysine 多聚L-赖氨酸;Fibronectin 纤连蛋白;Matrigel 基质胶;CAS:9007-34-5;

产品信息:

产品名称 产品编号 规格 价格(元)
Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I MX0910-2ML 2ml (10mg) 450
Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I MX0910-10ML 10ml (50mg) 2000

基本介绍:

胶原蛋白是结缔组织和内脏器官细胞外基质的主要构造成分,但在皮肤、肌腱、骨骼中分布最为广泛。从遗传和结构上胶原蛋白分为许多类型。胶原蛋白I(Collagen, Type I)是由2个α1链和1个α2链组成的异源多聚体,在37℃,中性pH下自发形成三螺旋骨架,是一种优秀的细胞培养用基质,广泛用于肝细胞、成纤维细胞、脊神经节、肌肉细胞、施万细胞、胚肺细胞、上皮细胞和其他大量细胞系。还能用于研究细胞生长、分化、迁移以及发育过程中的组织形态发生。

金畔生物提供的鼠尾胶原蛋白I是根据Birkedal-Hansen方法,通过醋酸抽提、氯化钠沉淀、磷酸氢二钠沉淀等步骤制备。可用于包被细胞培养器皿,培养细胞表面粘附性,特别适合那些在普通培养器皿表面不易贴壁的细胞,比如成纤维细胞、肝细胞等原代细胞。还可用于三维胶的制备,模拟真实的生长环境,使得细胞在三维环境中生长。

本品为溶于6mM HAc的无菌溶液,浓度5mg/ml,每个批次产品皆通过细胞培养测试(包括三维空间培养)以保证质量的可靠性。

保存与运输方法:

保存:2-8℃保存,不可冻存,一年有效。

运输:冰袋运输。

注意事项

1)整个操作请于冰上进行,因室温鼠尾胶原I可迅速成胶,操作过程尽量保持低温。

2)整个操作请在无菌环境下无菌操作,避免污染以影响细胞生长。

3)为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用方法

1. 细胞培养器皿的表面包被

组织培养器皿的表面包被推荐浓度为1-5µg/cm2,起始浓度可首选5µg/cm2。建议根据具体细胞类型来优化。

1.1 6mM HAc稀释液的制备

本品以溶于6mM HAc(=0.36g/L HAc)的无菌溶液形式提供,本身不溶于中性pH,建议用6mM HAc溶液做进一步稀释。

配制方法:取34.5µl冰醋酸(17.4 M)加入100ml双蒸水,充分混匀后即得到6mM HAc溶液,0.22µm滤膜过滤除菌后待用。

1.2 包被步骤

a,根据自身实验体系以及优化后的包被浓度来计算所需的胶原蛋白量,并加入相应孔内,确保胶原蛋白溶液完全覆盖表面。

1)以包被浓度为5µg/cm2,先用6mM HAc稀释液将胶原蛋白(5mg/ml)稀释到合适的中间浓度,如50µg/ml,然后参考表1不同培养皿内胶原蛋白加量表来加量到各孔内;

2)以包被浓度为2µg/cm2,先用6mM HAc稀释液将胶原蛋白(5mg/ml)稀释到合适的中间浓度,如12µg/ml,然后参考表1不同培养皿内胶原蛋白加量表来加量到各孔内;

表1 不同培养皿内胶原蛋白加量表

培养皿类型 每孔/皿表面积(cm2) 当包被浓度:2µg/cm2,中间稀释浓度:12µg/ml,加入该稀释液的体积(µl) 当包被浓度:5µg/cm2,中间稀释浓度:50µg/ml,加入该稀释液的体积(µl)
96 well 0.3 50 30
24 well 1.9 300 190
12 well 3.8 600 380
6 well 9.5 1580 950
35mm 8 1330 800
60mm 21 3500 2100
100mm 55 9170 5500

b,室温孵育1h,小心吸掉多余液体,用无菌PBS清洗3~4次后直接使用。或者加完胶原蛋白溶液后,在超净台内开盖过夜晾干。无菌条件下,包被好的器皿在4-25℃至少可保存3个月。

2. 三维胶原的制备

当鼠尾胶原蛋白I使用浓度>1mg/ml,pH 7.0左右皆可形成具有一定强度的三维胶,建议成胶浓度为1-2 mg/ml。

由于本品是以溶于6mM HAc的无菌溶液形式提供,在成胶过程需先加入0.06倍体积的0.1M NaOH中和。

2.1 需要溶液准备(无菌、预冷)

10×PBS(可含酚红)或10×细胞培养液

0.1M NaOH

双蒸水

2.2 三维胶原制备(不含细胞)(以配制1ml,1mg/ml三维胶为例):

a,取200µl胶原蛋白(5mg/ml)加到置于冰浴的离心管内,加入690µl无菌水。之后加到12µl 0.1M NaOH【注意:该步骤不能反,如果反过来把12µl 0.1M NaOH加到胶原溶液中,会由于NaOH不能迅速混匀而产生局部的胶原凝结】,立即混匀。再加入100µl 10×PBS或10×细胞培养液,混匀后立即加到培养器皿中【注意:混匀后pH为7.0左右,如果PBS或培养液中没有加酚红,初次使用时需要用pH试纸测试】。

b,将培养器皿在室温(25℃左右)放置20min待胶凝固后,转移到培养箱内。【注意】:如果配制中使用的是10×PBS,需要在做细胞培养前,先加入适当体积的细胞培养液预平衡。

2.3 三维胶原制备(含细胞)(以配制1ml,1mg/ml三维胶为例):

a,准备好细胞悬液,并放置于冰浴中。

b,将200µl胶原蛋白(5mg/ml)加到12µl 0.1M NaOH【注意:该步骤不能反,如果反过来把12µl 0.1M NaOH加到胶原溶液中,会由于NaOH不能迅速混匀而产生局部的胶原凝结】,立即混匀。再加入23µl 10×PBS或者10×细胞培养液,立即混匀【注意:混匀后pH为7.0左右,如果PBS或培养液中没有加酚红,初次使用时需要用pH试纸测试】。再加入760µl的细胞悬浮液,混匀后立即加到培养器皿中。

c,将培养器皿在室温(25℃左右)放置20min待胶凝固后,加入适当体积细胞培养液,转移到培养箱中培养。

相关产品:

MX0910-2ML Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I 2ml(10mg)
MX0911-100G Gelatin, Type A 明胶(A型) 100g
MX0917-25MG Poly-L-lysine (Mw 70,000-150,000) 多聚L-赖氨酸 25mg
MX0918-25MG Poly-L-lysine (Mw 150,000-300,000) 多聚L-赖氨酸 25mg
MX0921-25MG Poly-D-lysine (Mw 70,000-150,000) 多聚D-赖氨酸 25mg
MX0918-25MG Poly-L-lysine (Mw 150,000-300,000) 多聚L-赖氨酸 25mg
MX0922-10MG Poly-D-lysine (Mw 150,000-300,000) 多聚D-赖氨酸 10mg
MX0926-5MG Fibronectin from Human Plasma 人纤连蛋白 5mg
MX0928-1MG Laminin from Mouse EHS sarcoma小鼠层粘连蛋白 1mg

Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I


描述

搜索关键词:

Extracellular Matrix (ECM) 细胞外基质;Gelatin 明胶;Collagen Type I 胶原蛋白I型;Poly-L-lysine 多聚L-赖氨酸;Fibronectin 纤连蛋白;Matrigel 基质胶;CAS:9007-34-5;

产品信息:

产品名称 产品编号 规格 价格(元)
Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I MX0910-2ML 2ml (10mg) 450
Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I MX0910-10ML 10ml (50mg) 2000

基本介绍:

胶原蛋白是结缔组织和内脏器官细胞外基质的主要构造成分,但在皮肤、肌腱、骨骼中分布最为广泛。从遗传和结构上胶原蛋白分为许多类型。胶原蛋白I(Collagen, Type I)是由2个α1链和1个α2链组成的异源多聚体,在37℃,中性pH下自发形成三螺旋骨架,是一种优秀的细胞培养用基质,广泛用于肝细胞、成纤维细胞、脊神经节、肌肉细胞、施万细胞、胚肺细胞、上皮细胞和其他大量细胞系。还能用于研究细胞生长、分化、迁移以及发育过程中的组织形态发生。

金畔生物提供的鼠尾胶原蛋白I是根据Birkedal-Hansen方法,通过醋酸抽提、氯化钠沉淀、磷酸氢二钠沉淀等步骤制备。可用于包被细胞培养器皿,培养细胞表面粘附性,特别适合那些在普通培养器皿表面不易贴壁的细胞,比如成纤维细胞、肝细胞等原代细胞。还可用于三维胶的制备,模拟真实的生长环境,使得细胞在三维环境中生长。

本品为溶于6mM HAc的无菌溶液,浓度5mg/ml,每个批次产品皆通过细胞培养测试(包括三维空间培养)以保证质量的可靠性。

保存与运输方法:

保存:2-8℃保存,不可冻存,一年有效。

运输:冰袋运输。

注意事项

1)整个操作请于冰上进行,因室温鼠尾胶原I可迅速成胶,操作过程尽量保持低温。

2)整个操作请在无菌环境下无菌操作,避免污染以影响细胞生长。

3)为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用方法

1. 细胞培养器皿的表面包被

组织培养器皿的表面包被推荐浓度为1-5µg/cm2,起始浓度可首选5µg/cm2。建议根据具体细胞类型来优化。

1.1 6mM HAc稀释液的制备

本品以溶于6mM HAc(=0.36g/L HAc)的无菌溶液形式提供,本身不溶于中性pH,建议用6mM HAc溶液做进一步稀释。

配制方法:取34.5µl冰醋酸(17.4 M)加入100ml双蒸水,充分混匀后即得到6mM HAc溶液,0.22µm滤膜过滤除菌后待用。

1.2 包被步骤

a,根据自身实验体系以及优化后的包被浓度来计算所需的胶原蛋白量,并加入相应孔内,确保胶原蛋白溶液完全覆盖表面。

1)以包被浓度为5µg/cm2,先用6mM HAc稀释液将胶原蛋白(5mg/ml)稀释到合适的中间浓度,如50µg/ml,然后参考表1不同培养皿内胶原蛋白加量表来加量到各孔内;

2)以包被浓度为2µg/cm2,先用6mM HAc稀释液将胶原蛋白(5mg/ml)稀释到合适的中间浓度,如12µg/ml,然后参考表1不同培养皿内胶原蛋白加量表来加量到各孔内;

表1 不同培养皿内胶原蛋白加量表

培养皿类型 每孔/皿表面积(cm2) 当包被浓度:2µg/cm2,中间稀释浓度:12µg/ml,加入该稀释液的体积(µl) 当包被浓度:5µg/cm2,中间稀释浓度:50µg/ml,加入该稀释液的体积(µl)
96 well 0.3 50 30
24 well 1.9 300 190
12 well 3.8 600 380
6 well 9.5 1580 950
35mm 8 1330 800
60mm 21 3500 2100
100mm 55 9170 5500

b,室温孵育1h,小心吸掉多余液体,用无菌PBS清洗3~4次后直接使用。或者加完胶原蛋白溶液后,在超净台内开盖过夜晾干。无菌条件下,包被好的器皿在4-25℃至少可保存3个月。

2. 三维胶原的制备

当鼠尾胶原蛋白I使用浓度>1mg/ml,pH 7.0左右皆可形成具有一定强度的三维胶,建议成胶浓度为1-2 mg/ml。

由于本品是以溶于6mM HAc的无菌溶液形式提供,在成胶过程需先加入0.06倍体积的0.1M NaOH中和。

2.1 需要溶液准备(无菌、预冷)

10×PBS(可含酚红)或10×细胞培养液

0.1M NaOH

双蒸水

2.2 三维胶原制备(不含细胞)(以配制1ml,1mg/ml三维胶为例):

a,取200µl胶原蛋白(5mg/ml)加到置于冰浴的离心管内,加入690µl无菌水。之后加到12µl 0.1M NaOH【注意:该步骤不能反,如果反过来把12µl 0.1M NaOH加到胶原溶液中,会由于NaOH不能迅速混匀而产生局部的胶原凝结】,立即混匀。再加入100µl 10×PBS或10×细胞培养液,混匀后立即加到培养器皿中【注意:混匀后pH为7.0左右,如果PBS或培养液中没有加酚红,初次使用时需要用pH试纸测试】。

b,将培养器皿在室温(25℃左右)放置20min待胶凝固后,转移到培养箱内。【注意】:如果配制中使用的是10×PBS,需要在做细胞培养前,先加入适当体积的细胞培养液预平衡。

2.3 三维胶原制备(含细胞)(以配制1ml,1mg/ml三维胶为例):

a,准备好细胞悬液,并放置于冰浴中。

b,将200µl胶原蛋白(5mg/ml)加到12µl 0.1M NaOH【注意:该步骤不能反,如果反过来把12µl 0.1M NaOH加到胶原溶液中,会由于NaOH不能迅速混匀而产生局部的胶原凝结】,立即混匀。再加入23µl 10×PBS或者10×细胞培养液,立即混匀【注意:混匀后pH为7.0左右,如果PBS或培养液中没有加酚红,初次使用时需要用pH试纸测试】。再加入760µl的细胞悬浮液,混匀后立即加到培养器皿中。

c,将培养器皿在室温(25℃左右)放置20min待胶凝固后,加入适当体积细胞培养液,转移到培养箱中培养。

相关产品:

MX0910-2ML Collagen, Type I, from Rat Tail 鼠尾胶原蛋白I 2ml(10mg)
MX0911-100G Gelatin, Type A 明胶(A型) 100g
MX0917-25MG Poly-L-lysine (Mw 70,000-150,000) 多聚L-赖氨酸 25mg
MX0918-25MG Poly-L-lysine (Mw 150,000-300,000) 多聚L-赖氨酸 25mg
MX0921-25MG Poly-D-lysine (Mw 70,000-150,000) 多聚D-赖氨酸 25mg
MX0918-25MG Poly-L-lysine (Mw 150,000-300,000) 多聚L-赖氨酸 25mg
MX0922-10MG Poly-D-lysine (Mw 150,000-300,000) 多聚D-赖氨酸 10mg
MX0926-5MG Fibronectin from Human Plasma 人纤连蛋白 5mg
MX0928-1MG Laminin from Mouse EHS sarcoma小鼠层粘连蛋白 1mg

抗体/试剂/诊断抗体原料,I型胶原蛋白抗体 | RabbitAnti-Collagen I antibody

品牌:Bioss/博奥森 | 货号:JP-0578R

产品编号 JP-0578R
英文名称 Collagen I
中文名称 I型胶原蛋白抗体
别    名 Collagen type I; Alpha 1 type I collagen; Alpha 2 type I collagen; COL1A1; COL1A2; Collagen I alpha 1 polypeptide; Collagen I alpha 2 polypeptide; Collagen Of Skin Tendon And Bone; Collagen Type 1; Collagen type I alpha 1; Collagen type I alpha 2; OI4; Osteogenesis Imperfecta Type IV; Pro alpha 1(I) collagen; Type I procollagen; CO1A1_HUMAN; Collagen alpha-1(II) chain; Alpha-1 type II collagen; Collagen alpha-1(II) chain; Chondrocalcin; collagen alpha-1(I) chain preproprotein; Collagen Ⅰ.  胶原蛋白1; 1型胶原蛋白; I型胶原;
Specific References  (118)     |     JP-0578R has been referenced in 118 publications.
111 [IF=7.7] Yang, Fan, et al. “Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling.” Stem Cells 29.6 (2011): 981-991.  Human, Rat.  222

111 [IF=3.82] Luo, Yang, et al. “Alendronate Retards the Progression of Lumbar Intervertebral Disc Degeneration in Ovariectomized Rats.” Bone (2013).  IHC-P ;  Rat.  222

111 [IF=3.61] Xu, Zhen E., et al. “Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice.” American Journal of Physiology-Renal Physiology 301.4 (2011): F713-F722.  IHC-P ;  Mouse.  222

111 [IF=3.55] Guo, Hong-Feng, et al. “Piezoelectric PU/PVDF electrospun scaffolds for wound healing applications.” Colloids and Surfaces B: Biointerfaces (2012).  WB ;  Mouse.  222

111 [IF=1.97] Zhang, Qiang-Ye, et al. “Administration of a novel penicillamine-bound membrane: a preventive and therapeutic treatment for abdominal adhesions.” BMC surgery 11.1 (2011): 5.  Rat.  222

111 [IF=2.16] Zhou, Nan, et al. “Involvement of Imperatorin Derivative‐OW1 in the antihypertensive effect and vascular remodeling of renovascular hypertension rats.” Clinical and Experimental Pharmacology and Physiology (2014).  IHC-P ;  Rat.  222

111 [IF=4.45] Wang, Chen-Chie, et al. “Expandable Scaffold Improves Integration of Tissue Engineered Cartilage: An In Vivo Study in A Rabbit Model.” Tissue Engineering ja (2016).  IHC-P ;  Rabbit.  222

111 [IF=2.07] Chen, Cheng, et al. “Effects of Cytoskeleton Modulation on the Phenotype of Articular Chondrocytes in Monolayer and Pellet Culture.” Journal of Biomaterials and Tissue Engineering 5.12 (2015): 942-950.  IHC-P ;  Rabbit.  222

111 [IF=1.93] Gao, Yuanyuan, et al. “TGF‐β1 promotes bovine mammary fibroblast proliferation through the ERK 1/2 signalling pathway.” Cell biology international (2016).  IHC-P ;  Bovine.  222

111 [IF=.68] Çakir-Özkan, Nilüfer, et al. “Therapeutic Effects of Sildenafil on Experimental Mandibular Fractures.” Journal of Craniofacial Surgery 27.3 (2016): 615-620.  IHC-P ;  Rat.  222

111 [IF=3.42] Cecen, Berivan, et al. “Biocompatibility and biomechanical characteristics of loofah based scaffolds combined with hydroxyapatite, cellulose, poly-l-lactic acid with chondrocyte-like cells.” Materials Science and Engineering: C(2016).  IHC ;  Human.  222

111 [IF=1.68] Ren, Xiang, et al. “Engineering zonal cartilage through bioprinting collagen type II hydrogel constructs with biomimetic chondrocyte density gradient.”BMC Musculoskeletal Disorders 17.1 (2016): 1.  IHC-P ;  Rabbit.  222

111 [IF=1.28] Tian, Fa‑Ming, et al. “Orally administered simvastatin partially preserves lumbar vertebral bone mass but not integrity of intervertebral discs in ovariectomized rats.” Experimental and Therapeutic Medicine.  IHC-P ;  Rat.  222

111 [IF=3.365] Yang, Ning, et al. “Caffeic acid phenethyl ester up-regulates antioxidant levels in hepatic stellate cell line T6 via an Nrf2-mediated mitogen activated protein kinases pathway.” World J Gastroenterol 23.7 (2017): 1203-1214.  WB ;  Rat.  222

111 [IF=5.168] Yu, Chengyuan, et al. “Chronic obstructive sleep apnea promotes aortic remodeling in canines through miR-145/Smad3 signaling pathway.” Oncotarget 8.23 (2017): 37705.  WB ;  Dog.  222

111 [IF=2.134] Wang et al. The influence of hypoxia during different pregnancy stages on cardiac collagen accumulation in the adult offspring. (2014) Biomed.Res.In. 2014:419805  WB ;  Rat.  222
PubMed:25013780

111 [IF=.971] Yang et al. Isolation and biological characterization of tendon-derived stem cells from fetal bovine. (2016) In.Vitro.Cell.Dev.Biol.Ani. 52:846-56  IF(ICC) ;  Rat.  222
PubMed:27130678

111 [IF=1.922] Chi et al. Transdermal estrogen gel and oral aspirin combination therapy improves fertility prognosis via the promotion of endometrial receptivity in moderate to severe intrauterine adhesion. (2018) Mol.Med.Rep. 17:6337-6344  IHC ;  Human.  222
PubMed:29512784

111 [IF=3.952] Yang KC et al. Low-adhesive ethylene vinyl alcohol-based packaging to xenogeneic islet encapsulation for type 1 diabetes treatment.Biotechnol Bioeng. 2018 Sep;115(9):2341-2355.  IHC-P ;  Rat.  222
PubMed:29777589

111 [IF=1.792] Huo YT et al. Methacholine induces extracellular matrix production by human airway smooth muscle cells through -catenin signaling.Respiratory Physiology & Neurobiology, 254, 55–63.  IF ;  Human.  222

111 [IF=3.234] Fan S et al. Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway.Life Sci. 2018 Aug 15;207:205-211.  WB ;  Rat.  222
PubMed:29883721

111 [IF=2.25] Zhang X et al. Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1/S1P signaling.Biochem Cell Biol. 2018 Dec;96(6):742-751.  WB ;  Mouse&Human.  222
PubMed:29940125

111 [IF=2.634] Ma C et al. Identification and Multilineage Potential Research of a Novel Type of Adipose-Derived Mesenchymal Stem Cells from Goose Inguinal Groove. DNA Cell Biol. 2018 Sep;37(9):731-741.  ICF ;  Goose.  222
PubMed:30102556

111 [IF=1.664] Gao S et al. Abnormal changes in the quantity and function of osteoblasts cultured in patients with myelodysplastic syndrome. Oncol Lett. 2018 Oct;16(4):4384-4390.  ICC ;  Human.  222
PubMed:30214573

111 [IF=3.166] Wang Y et al. ASIC1a promotes high glucose and PDGF-induced hepatic stellate cell activation by inducing autophagy through CaMKKβ/ERK signaling pathway. (2018) Toxicol Lett. (18)31963-5  WB ;  Rat.  222
PubMed:30291941

111 [IF=4.427] Wu M et al. Synergistic effects of sulfur dioxide and polycyclic aromatic hydrocarbons on pulmonary pro-fibrosis via mir-30c-1-3p/transforming growth factor β type II receptor axis.(2018) Chemosphere 219  WB ;  Mouse&Human.  222
PubMed:30543962

111 [IF=3.373] Niu L et al. PLGA/PLCA casting and PLGA/PDPA electrospinning bilayer film for prevention of postoperative adhesion. (2018) J. Biomed. Mater. Res. Part B Appl. Biomater.  IHC-P ;  Rabbit.  222
PubMed:30548816

111 [IF=1.564] Liu P et al. Matrine Suppresses Pancreatic Fibrosis by Regulating TGF-β/Smad Signaling in Rats. (2019) Yonsei Med. J. 60(1)  IHC-P ;  Rat.  222
PubMed:30554494

111 [IF=3.909] Kara A et al. Bioactive fish scale incorporated chitosan biocomposite scaffolds for bone tissue engineering. Int J Biol Macromol. 2019 Feb 20;130:266-279.  SEM, fluorescence microscopy&IHC ;  Fish(Sparus aurata).  222
PubMed:30797008

111 [IF=4.938] Li Y et al. Klotho recovery by genistein via promoter histone acetylation and DNA demethylation mitigates renal fibrosis in mice.J Mol Med (Berl). 2019 Apr;97(4):541-552.  WB ;  Mouse&Human.  222
PubMed:30806715

研究领域 细胞生物  免疫学  
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 Human, Mouse, Rat, Dog, Rabbit,  (predicted: Cow, Horse, Sheep, Monkey, )
产品应用 WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理论分子量 130kDa
细胞定位 细胞外基质 分泌型蛋白 
性    状 Liquid
浓    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human Collagen I C-terminal propeptide: 1321-1400/1464 
亚    型 IgG
纯化方法 affinity purified by Protein A
缓 冲 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件 Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
产品介绍 This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008].

Function:
Type I collagen is a member of group I collagen (fibrillar forming collagen).

Subunit:
Trimers of one alpha 2(I) and two alpha 1(I) chains. Interacts with MRC2. Interacts with TRAM2.

Subcellular Location:
Secreted, extracellular space, extracellular matrix.

Tissue Specificity:
Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.

Post-translational modifications:
Proline residues at the third position of the tripeptide repeating unit (G-X-P) are hydroxylated in some or all of the chains. Proline residues at the second position of the tripeptide repeating unit (G-P-X) are hydroxylated in some of the chains.
O-linked glycan consists of a Glc-Gal disaccharide bound to the oxygen atom of a post-translationally added hydroxyl group.

DISEASE:
Defects in COL1A1 are the cause of Caffey disease (CAFFD) [MIM:114000]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age.
Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000]; also known as Ehlers-Danlos syndrome gravis. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS1 is the severe form of classic Ehlers-Danlos syndrome.
Defects in COL1A1 are the cause of Ehlers-Danlos syndrome type 7A (EDS7A) [MIM:130060]; also known as autosomal dominant Ehlers-Danlos syndrome type VII. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7A is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 1 (OI1) [MIM:166200]. A dominantly inherited connective tissue disorder characterized by bone fragility and blue sclerae. Osteogenesis imperfecta type 1 is non-deforming with normal height or mild short stature, and no dentinogenesis imperfecta.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 2 (OI2) [MIM:166210]; also known as osteogenesis imperfecta congenita. A connective tissue disorder characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 3 (OI3) [MIM:259420]. A connective tissue disorder characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera, and dentinogenesis imperfecta.
Defects in COL1A1 are a cause of osteogenesis imperfecta type 4 (OI4) [MIM:166220]; also known as osteogenesis imperfecta with normal sclerae. A connective tissue disorder characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta.
Genetic variations in COL1A1 are a cause of susceptibility to osteoporosis (OSTEOP) [MIM:166710]; also known as involutional or senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mass, disruption of bone microarchitecture without alteration in the composition of bone. Osteoporotic bones are more at risk of fracture.
Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.

Similarity:
Belongs to the fibrillar collagen family.
Contains 1 fibrillar collagen NC1 domain.
Contains 1 VWFC domain.

SWISS:
P02452

Gene ID:
1277

Database links:

· Entrez Gene: 1277 Human

· Entrez Gene: 12842 Mouse

· Entrez Gene: 100008952 Rabbit

· Entrez Gene: 29393 Rat

· Omim: 120150 Human

· SwissProt: P02453 Cow

· SwissProt: O46392 Dog

· SwissProt: P02452 Human

· SwissProt: P11087 Mouse

· SwissProt: P02454 Rat

· Unigene: 172928 Human

· Unigene: 277735 Mouse

· Unigene: 107239 Rat

I型胶原是软骨基质中的一种结构蛋白 。
主要用于Ⅰ型胶原分布及变态反应方面的研究。

产品图片
Sample:
Lane 1: HepG2 (Human) Cell Lysate at 30 ug
Primary: Anti-Collagen I (JP-0578R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 130,110 kD
Observed band size: 130 kD

Sample:
Lane 1: Placenta (Mouse) Lysate at 40 ug
Lane 2: U-2OS (Human) Cell Lysate at 30 ug
Primary: Anti-Collagen I (JP-0578R) at 1/1000 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 130,110 kD
Observed band size: 130 kD

Tissue/cell: human lung carcinoma; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
Incubation: Anti-Collagen I Polyclonal Antibody, Unconjugated(JP-0578R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining

Tissue/cell: rat colon tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
Incubation: Anti-Collagen I Polyclonal Antibody, Unconjugated(JP-0578R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining

本网站可提供的所有产品和服务均不得用于人体或动物的临床诊断或治疗,仅可用于科研等非医疗目的。

抗体/试剂/诊断抗体原料,JP-10423R,Bioss/博奥森代理,I型胶原蛋白/胶原蛋白1/1型胶原蛋白/I型胶原a1抗体 Collagen I

品牌:Bioss/博奥森 | 货号:JP-10423R 产品编号  JP-10423R
英文名称  Collagen I
中文名称  I型胶原蛋白/胶原蛋白1/1型胶原蛋白/I型胶原a1抗体
别    名     Collagen type I; Alpha 1 type I collagen; Alpha 2 type I collagen; COL1A1; COL1A2; Collagen I alpha 1 polypeptide; Collagen I alpha 2 polypeptide; Collagen Of Skin Tendon And Bone; Collagen Type 1; Collagen type I alpha 1; Collagen type I alpha 2; OI4; Osteogenesis Imperfecta Type IV; Pro alpha 1(I) collagen; Type I procollagen; CO1A1_HUMAN.  

本网站可提供的所有产品和服务均不得用于人体或动物的临床诊断或治疗,仅可用于科研等非医疗目的。

beMatrix® Collagen 低毒素胶原(活体组织工程用)

beMatrix® Collagen

低毒素胶原(活体组织工程用)

 

本系列产品为低内毒素、高安全性的胶原,经过内毒素控制、病毒灭活处理。

应用研究领域:再生医疗、分析研发、生物材料、医疗及诊断器械、人工组织及器官

 

 

◆beMatrix® Collagen AT

 

beMatrix® Collagen 低毒素胶原(活体组织工程用)

猪腱来源酸提取胶原溶液

 

●  内毒素水平:0.5 EU/mL以下

●  保存条件:冷藏保存(4°C~8°C)

●  有效期:两年

●  浓度:3 mg/mL [pH 3]

 

 

◆ beMatrix® Collagen TE

 

beMatrix® Collagen 低毒素胶原(活体组织工程用)

 

猪皮来源胃蛋白酶溶解性胶原溶液 

 

●  内毒素水平:0.5 EU/mL以下

●  保存条件:冷藏保存(4°C~8°C)

●  有效期:两年

●  浓度:5 mg/mL [pH 3]

 

 

◆beMatrix® Collagen FD

 

beMatrix® Collagen 低毒素胶原(活体组织工程用)

 

猪皮来源胃蛋白酶溶解性胶原冻干品

可制备高浓度胶原溶液 

 

●  内毒素水平:100 EU/g以下

●  保存条件:室温

●  有效期:两年

●  产品外观:白色海绵

●  尺寸:约140×100×10 mm

●  用途:

●  ·  支架

●  ·  细胞培养/移植

●  ·  电纺丝 等

※  本产品仅限于研究使用。不论使用目的(药物生产、品质管理、各类诊断、治疗以及研究等)。无论如何,都请勿将产品用于人体。

 


产品列表
产品编号 产品名称 产品规格 产品等级 备注
630-29801 beMatrix® Collagen AT 100 mL
637-29811 beMatrix® Collagen TE 100 mL
631-36781 beMatrix® Collagen FD 1 g

免责声明

1. 本公司密切关注本网站发布的内容,但不保证发布内容的准确性、完整性、可靠性和最新性等。

2. 本公司不保证使用本网站期间不会出现故障或计算机病毒污染的风险。

3. 无论何种原因,使用本网站时给用户或第三方造成的任何不利或损害,本公司概不负责。此外,对于用户与其他用户或第三方之间因本网站发生的任何交易、通讯

3. 纠纷,本公司概不负责。

4. 本网站可提供的所有产品和服务均不得用于人体或动物的临床诊断或治疗,仅可用于科研等非医疗目的。如任何用户将本网站提供的产品和服务用临床诊断或治

4. 疗,以及他特定的用途或行为,本公司概不保证其安全性和有效性,并且不负任何相关的法律责任。

代理Worthington 可溶性胶原蛋白 Collagen, Soluble

英文名:Collagen, Soluble货号:WLS001663-BULK规格:Bulk
Worthington主要研究覆盖生物技术和生命科学研究,诊断,生物制药和生物加工应用的高质量纯化酶,蛋白质,核酸和试剂盒。上海金畔生物科技有限公司代理Worthington产品,更多产品欢迎访问Worthington官网。

Worthington热销产品列表,现货供应

木瓜蛋白酶,Suspension 货号LS003126

Papain酶,suspension 货号LS003127

Hyaluronidase酶, Purified 货号LS005474

Worthington Collagenase, Type 4试剂 货号LS004188

胶原酶, Type 1 货号LS004196

Papain, Lyophilized木瓜蛋白酶 货号LS003119

代理Worthington 胶原蛋白 Collagen

英文名:Collagen货号:WLS001658-BULK规格:Bulk
Worthington主要研究覆盖生物技术和生命科学研究,诊断,生物制药和生物加工应用的高质量纯化酶,蛋白质,核酸和试剂盒。上海金畔生物科技有限公司代理Worthington产品,更多产品欢迎访问Worthington官网。

Worthington热销产品列表,现货供应

木瓜蛋白酶,Suspension 货号LS003126

Papain酶,suspension 货号LS003127

Hyaluronidase酶, Purified 货号LS005474

Worthington Collagenase, Type 4试剂 货号LS004188

胶原酶, Type 1 货号LS004196

Papain, Lyophilized木瓜蛋白酶 货号LS003119

代理Worthington 胶原蛋白 Collagen

英文名:Collagen货号:WLS001656-10GM规格:10gm
Worthington主要研究覆盖生物技术和生命科学研究,诊断,生物制药和生物加工应用的高质量纯化酶,蛋白质,核酸和试剂盒。上海金畔生物科技有限公司代理Worthington产品,更多产品欢迎访问Worthington官网。

Worthington热销产品列表,现货供应

木瓜蛋白酶,Suspension 货号LS003126

Papain酶,suspension 货号LS003127

Hyaluronidase酶, Purified 货号LS005474

Worthington Collagenase, Type 4试剂 货号LS004188

胶原酶, Type 1 货号LS004196

Papain, Lyophilized木瓜蛋白酶 货号LS003119

代理Worthington 胶原蛋白 Collagen

英文名:Collagen货号:WLS001652-5GM规格:5gm
Worthington主要研究覆盖生物技术和生命科学研究,诊断,生物制药和生物加工应用的高质量纯化酶,蛋白质,核酸和试剂盒。上海金畔生物科技有限公司代理Worthington产品,更多产品欢迎访问Worthington官网。

Worthington热销产品列表,现货供应

木瓜蛋白酶,Suspension 货号LS003126

Papain酶,suspension 货号LS003127

Hyaluronidase酶, Purified 货号LS005474

Worthington Collagenase, Type 4试剂 货号LS004188

胶原酶, Type 1 货号LS004196

Papain, Lyophilized木瓜蛋白酶 货号LS003119

代理Worthington 胶原蛋白 Collagen

英文名:Collagen货号:WLS001654-1GM规格:1gm
Worthington主要研究覆盖生物技术和生命科学研究,诊断,生物制药和生物加工应用的高质量纯化酶,蛋白质,核酸和试剂盒。上海金畔生物科技有限公司代理Worthington产品,更多产品欢迎访问Worthington官网。

Worthington热销产品列表,现货供应

木瓜蛋白酶,Suspension 货号LS003126

Papain酶,suspension 货号LS003127

Hyaluronidase酶, Purified 货号LS005474

Worthington Collagenase, Type 4试剂 货号LS004188

胶原酶, Type 1 货号LS004196

Papain, Lyophilized木瓜蛋白酶 货号LS003119